Rock Springs Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Rock Springs Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-256,000	Closed	-$1.01M	–	142
2019 Q3	$1.01M	Hold	256,000	–	–	0.04%	132
2019 Q2	$3.81M	Hold	256,000	–	–	0.14%	117
2019 Q1	$6.35M	Hold	256,000	–	–	0.25%	100
2018 Q4	$4.6M	Sell	256,000 -15,100	-6%	-$309K	0.22%	100
2018 Q3	$7.96M	Buy	271,100 +16,100	+6%	+$623K	0.29%	95
2018 Q2	$11.6M	Buy	255,000 +23,500	+10%	+$1.14M	0.45%	77
2018 Q1	$12.2M	Hold	231,500	–	–	0.52%	68
2017 Q4	$15.7M	Hold	231,500	–	–	0.71%	50
2017 Q3	$19.1M	Hold	231,500	–	–	0.88%	41
2017 Q2	$21.7M	Buy	231,500 +47,000	+25%	+$2.88M	1.09%	30
2017 Q1	$11.7M	Buy	184,500 +74,500	+68%	+$4.53M	0.68%	48
2016 Q4	$4.89M	Sell	110,000 -15,000	-12%	-$528K	0.33%	78
2016 Q3	$4.51M	Hold	125,000	–	–	0.28%	92
2016 Q2	$1.72M	Hold	125,000	–	–	0.13%	118
2016 Q1	$2.4M	Hold	125,000	–	–	0.2%	106
2015 Q4	$4.38M	Buy	+125,000	New	+$8.06M	0.33%	92

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Rock Springs Capital Management's CLVS Position: Q4 2019 in Review

Rock Springs Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2019, closing a stake of 256,000 shares — an estimated $1.01M sold.

Rock Springs Capital Management first reported a position in CLVS in Q4 2015 and held it in 16 quarters. The position peaked at $21.7M in Q2 2017. 147 funds tracked by Wall St. Rank hold CLVS as of Q4 2019.

Rock Springs Capital Management reported no remaining Clovis Oncology, Inc. position as of Q4 2019 after selling out during the quarter.
Rock Springs Capital Management sold 256,000 Clovis Oncology, Inc. shares in Q4 2019, an estimated $1.01M.
Rock Springs Capital Management first reported a position in Clovis Oncology, Inc. in Q4 2015 and held it in 16 quarters.
Rock Springs Capital Management's Clovis Oncology, Inc. position peaked at $21.7M in Q2 2017.
147 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2019.

Based on Rock Springs Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.